comprehensive -WSS

comprehensive

author：focus 2025-09-29 02:46:38 - browse：92689

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Copay coupons to count toward deductibles, after Biden court move

Wikipedia

WSS

Readout Newsletter: Merck, J&J, and long Covid

Chan Zuckerberg Biohub Chicago to focus on inflammation

Why Charlie Gard's case is so disturbing to Americans

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Medicare Advantage today, explained in one chart

FDA panel signals lack of confidence in Amgen cancer drug data

hotspot

comprehensive

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

AI can decode, harness the power of the humane immune system

Alkermes shareholders re

Phenylephrine and the overlooked value of the placebo effect

Trump demands the U.S. pay no more for drugs than other countries … again

Copay coupons to count toward deductibles, after Biden court move

BioMarin wins approval for gene therapy to treat hemophilia A

The future of health care in the House

Wildfire smoke exposes gaps in outdoor worker protections

Francis Collins on trust in science and how Covid communications failed

focus

FDA rejects Alnylam's heart disease treatment over insufficient data

3 questions for the future of Biden's cancer moonshot

FDA authorizes Novavax’s updated Covid

Stroke deaths set to near 10 million globally by 2050

EU regulator recommends expanding Mounjaro approval to obesity

Senate panel eyes new effort on drug shortages

entertainment

Wikipedia

explore

focus